Ocular Therapeutix (OCUL) Short Interest Ratio & Short Volume $7.15 -0.38 (-5.05%) As of 01:02 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ocular Therapeutix Short Interest DataOcular Therapeutix (OCUL) has a short interest of 12.59 million shares, representing 8.30% of the float (the number of shares available for trading by the public). This marks a -1.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.1, indicating that it would take 9.1 days of the average trading volume of 1.36 million shares to cover all short positions.Current Short Interest12,590,000 sharesPrevious Short Interest12,830,000 sharesChange Vs. Previous Month-1.87%Dollar Volume Sold Short$92.28 millionShort Interest Ratio9.1 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares159,022,000 sharesShort Percent of Float8.30%Today's Trading Volume681,892 sharesAverage Trading Volume1,362,954 sharesToday's Volume Vs. Average50% Short Selling Ocular Therapeutix? Sign up to receive the latest short interest report for Ocular Therapeutix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOCUL Short Interest Over TimeOCUL Days to Cover Over TimeOCUL Percentage of Float Shorted Over Time Remove Ads Ocular Therapeutix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202512,590,000 shares $92.28 million -1.9%8.3%9.1 $7.33 3/15/202512,830,000 shares $99.05 million +6.5%8.5%11 $7.72 2/28/202512,050,000 shares $86.04 million +3.9%7.9%11.6 $7.14 2/15/202511,600,000 shares $84.45 million +6.7%7.6%12.8 $7.28 1/31/202510,870,000 shares $83.70 million -2.6%N/A11.8 $7.70 1/15/202511,160,000 shares $90.73 million +3.9%N/A12.5 $8.13 12/31/202410,740,000 shares $91.72 million +2.6%N/A10.5 $8.54 12/15/202410,470,000 shares $90.98 million -1.8%N/A9.6 $8.69 11/30/202410,660,000 shares $105.43 million -1.1%N/A9.2 $9.89 11/15/202410,780,000 shares $98.74 million -14.9%N/A9.5 $9.16 Get the Latest News and Ratings for OCUL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. 10/31/202412,670,000 shares $133.42 million -4.5%N/A11.6 $10.53 10/15/202413,260,000 shares $135.65 million -18.1%N/A11.4 $10.23 9/30/202416,190,000 shares $140.85 million -7.3%N/A13.7 $8.70 9/15/202417,460,000 shares $157.14 million -4.9%N/A12.1 $9.00 8/31/202418,350,000 shares $161.85 million -2.2%N/A11.2 $8.82 8/15/202418,770,000 shares $157.10 million -1.7%N/A10.3 $8.37 7/31/202419,090,000 shares $161.50 million -6.3%N/A9.3 $8.46 7/15/202420,380,000 shares $171.80 million -4.5%N/A8.2 $8.43 6/30/202421,340,000 shares $145.97 million -8.7%N/A8.1 $6.84 6/15/202423,370,000 shares $134.38 million +4.0%N/A9.4 $5.75 5/31/202422,470,000 shares $128.08 million +5.9%N/A9.2 $5.70 5/15/202421,220,000 shares $133.47 million +0.7%N/A8.3 $6.29 4/30/202421,080,000 shares $99.92 million +43.9%N/A7.8 $4.74 4/15/202414,650,000 shares $114.27 million +24.1%N/A6.3 $7.80 3/31/202411,810,000 shares $107.47 million +28.9%N/A5.8 $9.10 3/15/20249,160,000 shares $86.65 million +93.3%N/A4.5 $9.46 2/29/20244,740,000 shares $47.68 million +19.4%N/A2.4 $10.06 2/15/20243,970,000 shares $27.23 million +0.3%N/A2.3 $6.86 1/31/20243,960,000 shares $19.25 million +18.2%N/A2.9 $4.86 1/15/20243,350,000 shares $14.71 million -23.5%N/A2.5 $4.39 12/31/20234,380,000 shares $19.53 million -3.5%N/A3.6 $4.46 12/15/20234,540,000 shares $17.84 million -14.0%N/A3.9 $3.93 11/30/20235,280,000 shares $13.09 million -9.1%7.0%5.9 $2.48 11/15/20235,810,000 shares $13.07 million +22.1%7.7%7.5 $2.25 10/31/20234,760,000 shares $13.57 million +9.4%6.3%6 $2.85 10/15/20234,350,000 shares $10.83 million +6.4%5.8%6.2 $2.49 9/30/20234,090,000 shares $12.84 million -1.7%5.4%5.7 $3.14 9/15/20234,160,000 shares $14.48 million +1.2%5.5%5.2 $3.48 8/31/20234,110,000 shares $15.54 million -16.5%5.5%3.8 $3.78 8/15/20234,920,000 shares $22.19 million -20.3%6.5%4.1 $4.51Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 7/31/20236,170,000 shares $28.01 million -8.2%N/A5.1 $4.54 7/15/20236,720,000 shares $32.05 million -1.2%N/A5.2 $4.77 6/30/20236,800,000 shares $35.09 million +4.3%N/A5.4 $5.16 6/15/20236,520,000 shares $32.40 million -2.0%N/A5.2 $4.97 5/31/20236,650,000 shares $42.56 million +20.3%N/A6.8 $6.40 5/15/20235,530,000 shares $35.00 million +14.3%N/A5.4 $6.33 4/30/20234,840,000 shares $30.01 million +13.4%N/A3.1 $6.20 4/15/20234,270,000 shares $22.46 million -7.2%N/A2.8 $5.26 3/31/20234,600,000 shares $24.24 million +2.7%N/A3.2 $5.27 3/15/20234,480,000 shares $22.85 million +12.6%N/A3.1 $5.10 2/28/20233,980,000 shares $24.04 million +27.2%N/A2.9 $6.04 2/15/20233,130,000 shares $19.06 million +6.5%4.1%2.4 $6.09 1/31/20232,940,000 shares $11.50 million +4.3%3.9%4.6 $3.91 1/15/20232,820,000 shares $11.28 million -5.1%N/A4.3 $4.00 12/30/20222,970,000 shares $8.35 million -2.3%N/A4.5 $2.81 12/15/20223,040,000 shares $8.42 million +4.1%N/A3.5 $2.77 11/30/20222,920,000 shares $8.67 million -0.3%N/A3.5 $2.97 11/15/20222,930,000 shares $9.43 million -12.0%N/A3.4 $3.22 10/31/20223,330,000 shares $12.02 million +2.2%N/A3.8 $3.61 10/15/20223,260,000 shares $13.43 million +9.4%N/A3.9 $4.12 9/30/20222,980,000 shares $12.37 million +2.4%N/A3.8 $4.15 9/15/20222,910,000 shares $18.07 million -12.1%N/A5.4 $6.21 8/31/20223,310,000 shares $16.81 million -1.5%N/A6.1 $5.08 8/15/20223,360,000 shares $18.48 million -2.3%N/A6.1 $5.50 7/31/20223,440,000 shares $15.41 million -1.4%4.5%5.7 $4.48 7/15/20223,490,000 shares $15.11 million +3.3%4.6%5.5 $4.33 6/30/20223,380,000 shares $13.59 million -3.7%4.4%5 $4.02 6/15/20223,510,000 shares $12.46 million -11.1%4.6%5 $3.55 5/31/20223,950,000 shares $12.36 million +1.0%5.2%5.9 $3.13 5/15/20223,910,000 shares $12.82 million -2.5%5.1%5.8 $3.28 4/30/20224,010,000 shares $14.32 million -0.3%5.3%6.5 $3.57 4/15/20224,020,000 shares $17.61 million -4.1%5.3%6.5 $4.38 3/31/20224,190,000 shares $20.74 million -9.7%5.5%7.2 $4.95 3/15/20224,640,000 shares $23.76 million -0.6%6.1%7.6 $5.12 2/28/20224,670,000 shares $26.06 million +20.4%6.1%7 $5.58 2/15/20223,880,000 shares $21.65 million +15.8%5.1%5.6 $5.58 1/31/20223,350,000 shares $18.96 million +5.4%4.4%4.4 $5.66 1/15/20223,180,000 shares $19.72 million -0.9%4.2%3.6 $6.20 12/31/20213,210,000 shares $22.37 million -4.5%4.2%2.8 $6.97 12/15/20213,360,000 shares $22.38 million +3.7%4.4%2.9 $6.66 11/30/20213,240,000 shares $22.16 million -13.8%4.3%2.8 $6.84 11/15/20213,760,000 shares $26.62 million -6.7%4.9%3.3 $7.08 10/29/20214,030,000 shares $26.76 million -14.6%5.3%3.7 $6.64 10/15/20214,720,000 shares $52.82 million -9.4%6.2%4.6 $11.19 9/30/20215,210,000 shares $52.10 million -10.6%6.8%6.2 $10.00 9/15/20215,830,000 shares $60.05 million +3.0%7.6%7.6 $10.30 8/31/20215,660,000 shares $59.77 million -1.4%7.4%7.4 $10.56 8/13/20215,740,000 shares $61.76 million -0.2%7.5%7.5 $10.76 7/30/20215,750,000 shares $63.31 million No Change7.6%6.9 $11.01 7/15/20215,750,000 shares $73.08 million -1.0%7.6%5.5 $12.71Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 6/30/20215,810,000 shares $82.39 million -9.9%7.7%5.5 $14.18 6/15/20216,450,000 shares $87.85 million -8.8%8.5%5.9 $13.62 5/28/20217,070,000 shares $102.94 million +18.8%9.3%6.4 $14.56 5/14/20215,950,000 shares $89.07 million +10.4%N/A5.2 $14.97 4/30/20215,390,000 shares $103.27 million +12.3%N/A4.5 $19.16 4/15/20214,800,000 shares $79.20 million -6.8%N/A5.1 $16.50 3/31/20215,150,000 shares $82.37 million -4.1%N/A5.4 $16.00 3/15/20215,370,000 shares $111.91 million +5.9%N/A5.4 $20.84 2/26/20215,070,000 shares $91.82 million +6.7%N/A4.6 $18.11 2/12/20214,750,000 shares $93.86 million +3.5%N/A4.3 $19.76 1/29/20214,590,000 shares $85.51 million -15.0%N/A4.3 $18.63 1/15/20215,400,000 shares $115.78 million -7.4%N/A4.7 $21.44 12/31/20205,830,000 shares $118.47 million +16.6%N/A4.5 $20.32 12/15/20205,000,000 shares $111.60 million -17.2%N/A3.6 $22.32 11/30/20206,040,000 shares $105.22 million +4.1%N/A4.8 $17.42 11/15/20205,800,000 shares $80.62 million -5.7%N/A4.7 $13.90 10/30/20206,150,000 shares $58.36 million -11.3%N/A5.3 $9.49 10/15/20206,930,000 shares $76.44 million No ChangeN/A6.6 $11.03 9/30/20206,930,000 shares $52.74 million +6.5%N/A7.7 $7.61 9/15/20206,510,000 shares $55.73 million -0.5%N/A8.2 $8.56 8/31/20206,540,000 shares $56.90 million +16.0%N/A7.6 $8.70 8/14/20205,640,000 shares $45.06 million -2.4%N/A7.1 $7.99 7/31/20205,780,000 shares $45.32 million -2.2%N/A6.1 $7.84 7/15/20205,910,000 shares $44.62 million +0.5%N/A6 $7.55 6/30/20205,880,000 shares $48.98 million +4.6%N/A6.2 $8.33 6/15/20205,620,000 shares $46.39 million +3.1%N/A6.1 $8.26 5/29/20205,450,000 shares $38.37 million -0.7%N/A5.5 $7.04 5/15/20205,490,000 shares $37.74 million -9.9%N/A4.6 $6.88 4/30/20206,090,000 shares $35.08 million +6.8%N/A5.9 $5.76 OCUL Short Interest - Frequently Asked Questions What is Ocular Therapeutix's current short interest? Short interest is the volume of Ocular Therapeutix shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 12,590,000 shares of OCUL short. 8.30% of Ocular Therapeutix's shares are currently sold short. Learn More on Ocular Therapeutix's current short interest. What is a good short interest ratio for Ocular Therapeutix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUL shares currently have a short interest ratio of 9.0. Learn More on Ocular Therapeutix's short interest ratio. Which institutional investors are shorting Ocular Therapeutix? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocular Therapeutix: Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ocular Therapeutix? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.30% of Ocular Therapeutix's floating shares are currently sold short. Is Ocular Therapeutix's short interest increasing or decreasing? Ocular Therapeutix saw a decline in short interest in March. As of March 31st, there was short interest totaling 12,590,000 shares, a decline of 1.9% from the previous total of 12,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocular Therapeutix's short interest compare to its competitors? 8.30% of Ocular Therapeutix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ocular Therapeutix: Rhythm Pharmaceuticals, Inc. (8.03%), PTC Therapeutics, Inc. (7.44%), Organon & Co. (5.89%), Zai Lab Limited (7.77%), Arcellx, Inc. (17.25%), Avidity Biosciences, Inc. (15.29%), Ultragenyx Pharmaceutical Inc. (5.21%), Akero Therapeutics, Inc. (8.54%), SpringWorks Therapeutics, Inc. (12.05%), Protagonist Therapeutics, Inc. (8.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Ocular Therapeutix stock? Short selling OCUL is an investing strategy that aims to generate trading profit from Ocular Therapeutix as its price is falling. OCUL shares are trading down $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocular Therapeutix? A short squeeze for Ocular Therapeutix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUL, which in turn drives the price of the stock up even further. How often is Ocular Therapeutix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUL, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Rhythm Pharmaceuticals Short Interest Data PTC Therapeutics Short Interest Data Organon & Co. Short Interest Data Zai Lab Short Interest Data Arcellx Short Interest Data Avidity Biosciences Short Interest Data Ultragenyx Pharmaceutical Short Interest Data Akero Therapeutics Short Interest Data SpringWorks Therapeutics Short Interest Data Protagonist Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocular Therapeutix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCUL Stock Free OCUL Stock Alerts